SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 7/06/20 Avita Therapeutics, Inc. 8-K:4,9 6/30/20 2:26K Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 19K 2: EX-16.1 Letter re: Change in Certifying Accountant HTML 5K
EX-16.1 |
Exhibit 16.1
US Securities and Exchange Commission
Office of the Chief Accountant
100 F Street, NE
Washington, DC 20549
Re: Avita Therapeutics, Inc.
File No. 001-39059
Dear Sir or Madam:
We have read Item 4.01 of Form 8-K of Avita Therapeutics Inc. dated July 6, 2020 and agree with the statements concerning our Firm contained therein.
Very truly yours,
/s/ GRANT THORNTON AUDIT PTY LTD |
Sydney, NSW Australia |
July 3, 2020 |
This ‘8-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 7/6/20 | |||
7/3/20 | ||||
For Period end: | 6/30/20 | 8-K12B | ||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/26/21 AVITA Medical, Inc. 424B5 1:578K Donnelley … Solutions/FA 2/24/21 AVITA Medical, Inc. 424B5 1:578K Donnelley … Solutions/FA |